• Grifols Egypt is leading the national goal to achieve self-sufficiency in vital lifesaving plasma derivatives and create a fully integrated plasma platform
• Orange Business leverages its local expertise and service center to provide co-location services, building on its relationship with ACUD (Administrative Capital for Urban Development) data center

CAIRO: Orange Business is pleased to announce the successful completion of the first phase of a new data center and communications infrastructure for Grifols Egypt for its Plasma Derivatives (GEPD) facility in the Medical City within the New Administrative Capital.

The partnership involves delivering co-location services through the ACUD (Administrative Capital for Urban Development) commercial and telco data center. This includes communication services, support in equipment procurement, and professional services during the project build-up and upcoming operations.

Grifols Egypt for Plasma Derivatives (GEPD) is a joint venture between Egypt’s National Service Projects Organization (NSPO) and Grifols, a global healthcare company. Via this National Project, the pioneering company sets the roadmap for a more robust Egyptian healthcare system aiming to achieve self-sufficiency in plasma-derived medicines. This strategic project will guarantee a sustainable supply of essential therapeutics that are used as treatments for life-threatening diseases.

Orange Business is supporting Grifols Egypt in the critical set up of the project. With its global experience and over 25 years of operations in Egypt, coupled with its technical and system integration expertise, Orange Business possesses a comprehensive understanding of the regulatory and legal requirements essential for the project's success.

ACUD’s data center boasts an advanced infrastructure featuring state-of-the-art technology to meet the needs of businesses, from co-location services for dedicated server hosting to cloud hosting options. The data center is DBO (design, build and operate) certified.

Kristof Symons, CEO International at Orange Business commented: “We are delighted to put our experience at the service of this vital national health project in Egypt, and to contribute to its implementation and operations. This ambitious project empowered by Grifols Egypt for Plasma Derivatives (GEPD) should be an example of how private and government institutions are in the best position to enable fundamental changes for a country. Our technical skills, experienced resources, and global knowledge were pivotal in enabling Grifols to replicate its global business model in Egypt. This project shows how Orange Business can support its customers in creating a positive impact in today’s society.”

Dr. Ahmed Serag, Chief Strategy and Projects Officer in GEPD commented: "We are glad to announce this successful collaboration with Orange Business. This achievement enhances the GEPD strategy that prioritizes utilizing cutting edge technologies while ensuring a positive impact on the industry, economy and most importantly the quality of life for Egyptian patients.

"Grifols Egypt WAN will interconnect critical facilities, including a plasma laboratory, co-location data center, plasma warehouse, 20 plasma donation centers, and a state-of-the-art manufacturing facility. This comprehensive network infrastructure will ensure efficient operations and the timely delivery of plasma-derived medicines to patients in need,” added Dr. Serag.

Khaled Abbas, ACUD’s Chairman and Managing Director, praised the collaboration with Orange Business and the ongoing development of Egypt’s communication infrastructure and healthcare systems, which is set to benefit medical centers across the country, including the Medical City. He emphasized ACUD’s role in developing one of the Middle East’s leading regional data centers, integral to the Digital Egypt Strategy, and serving all New Administrative Capital (NAC) clients.

About Orange Business
Orange Business, the enterprise division of the Orange Group, is a leading network and digital integrator, supporting customers to create positive impact and digital business. The combined strength of its next-generation connectivity, cloud, and cybersecurity expertise, platforms, and partners provides the foundation for enterprises around the world. With 30,000 employees across 65 countries, Orange Business enables its customers’ transformations by orchestrating end-to-end secured digital infrastructure and focusing on the employee, customer, and operational experience. More than 30,000 B-to-B customers put their trust in Orange Business globally.

Orange is one of the world’s leading telecommunications operators with revenues of 39.7 billion euros in 2023 and 285 million customers worldwide at 30 June 2024. The Group is present in 26 countries (including non-consolidated countries). In February 2023, the Group presented its strategic plan "Lead the Future", built on a new business model and guided by responsibility and efficiency. "Lead the Future" capitalizes on network excellence to reinforce Orange's leadership in service quality.

Orange is listed on the Euronext Paris (ORA) and on the New York Stock Exchange (ORAN). For more information: www.orange-business.com or follow us on LinkedIn and on X: @orangebusiness
Orange and any other Orange product or service names included in this material are trademarks of Orange or Orange Brand Services Limited.

About Grifols Egypt for Plasma Derivatives
Grifols Egypt for Plasma Derivatives (GEPD) is a joint-venture company between Egypt’s National Service Projects Organization and Grifols. The strategic partnership’s combined expertise, technology and resources seeks to strengthen Egypt’s healthcare system through achieving self-sufficiency in plasma-derived medicines while reinforcing Grifols’ international expansion in the Middle East and Africa.

Fonte: Business Wire